Elpiscience Biopharma
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
987 Cailun Rd. 3f, Shanghai, Shanghai, C...Phone Number
+86 2150651310Website
www.elpiscience.comRevenue
$21.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elpiscience Biopharma
Elpiscience is a clinical stage biopharmaceutical company focused on innovation and development of cancer immunotherapies. The company was founded in 2017 and is headquartered in Shanghai, China.Explore more
Elpiscience Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elpiscience Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Elpiscience Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Elpiscience Biopharma has recently received funding, and reach out quickly before it becomes old news!
Elpiscience Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Elpiscience Biopharma has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Elpiscience Biopharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Elpiscience Biopharma
Check out if Elpiscience Biopharma is spiking on competitors!
Earning: See what the market has to say on Elpiscience Biopharma recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Elpiscience Biopharma as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Elpiscience Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elpiscience Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elpiscience Biopharma.
Elpiscience Biopharma financials insights
Gather financial insights about Elpiscience Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$20M
2019
Series B
$100M
2021
Series C
$105M
Elpiscience Biopharma Tech Stack
A closer look at the technologies used by Elpiscience Biopharma
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Partnership, Research & Development, Intellectual Property
Event
Events
Left Company
Executive Move
Funding
Elpiscience Biopharma News & Media
Elpiscience Announces Studies Presented at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide, presented studies for its innovative immunotherapeutic molecules at the SITC 2023 Annual Meeting, including KG2A/NKG2C dual-targeting antibody ES015-2, a high affinity LILRB1 specific blocking antibody ES008-a, and the first-in-class anti-CD39/TGF-βElpiscience Announces Three Poster Presentations at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide, today announced it will have three poster presentations at the SITC 2023 Annual Meeting taking place November 3-5, 2023, in San Diego. The posters will highlight its studies on three innovative molecules including a first-in-class NKG2A/NKG2C dual-t6 Immuno-oncology Startups Attracting the Biggest VC Cash
Check out Inside Precision Medicine's list of six private immuno-oncology startups around the world that have raised the biggest funding rounds in the last two years.Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--Elpiscience announced that the first patient has been dosed in a Phase 1 clinical trial of its anti-LILRB2 antibody ES009 in Australia.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elpiscience Biopharma
Sign Up For FreeTo access detailed company insights
Elpiscience is a clinical stage biopharmaceutical company focused on innovation and development of cancer immunotherapies. The company was founded in 2017 and is headquartered in Shanghai, China.... Read More
